Newspatrolling.com News cum Content Syndication Portal Online
It has been brought to the attention of the Exchange that following entities are allegedly engaged in unauthorised activities like investment/trading recommendations without Research Analyst Registration and soliciting funds from investors while impersonating as SEBI registered Research Analyst:
| Sr.
No |
Name | Contact | Online Presence |
| 1. | THE APEX | 8097882666 | Website: |
| STOCKS | https://theapexstocks.com | ||
| 8007700400 | |||
| Social Media: | |||
| https://www.facebook.com/ |
Please note that these individuals/entities are neither registered as member nor as Authorized Person of any registered member of the BSE Limited. The Exchange provides a facility to verify the registration of Exchange intermediaries at following links on the Exchange website:
| Sr. No | Intermediary | Path and Link |
| 1. | Member (Stockbroker) | Members -> Member Directory -> Members https://www.bseindia.com/ |
| 2. | Authorized Person | Members -> Member Directory -> Other Intermediaries https://www.bseindia.com/ |
| 3. | Investment Advisor | Investment Advisers ->Enlistment->BSE Enlisted IA https://www.bseindia.com/iara/ |
| 4. | Research Analyst | Research Analysts -> Enlistment -> BSE Enlisted RA https://www.bseindia.com/IARA/ |
The investors are cautioned and advised not to subscribe to any scheme/product offered by any person/entity offering indicative/assured/guaranteed returns in the stock market as the same is prohibited by law. Further, investors are advised not to share their trading credentials such as user id/password with anyone for trading in their account/handling of the portfolio.
Participation in such prohibited schemes is at investors’ own risk, cost and consequences as such schemes are neither approved nor endorsed by the Exchange.
The investors may note that for any kind of disputes relating to such prohibited schemes none of the following recourses will be available to investors:
1. Benefits of Investor Protection under Exchange’s Jurisdiction
2. Exchange Dispute Resolution Mechanism
3. Investor Grievance Redressal Mechanism administered by Exchange.
Investors are advised to take note of the above.
